Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NYSEFinancialsFinancial - Credit ServicesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
6.34 → 6.00 EPS · FY ending Dec 31, 2027 · 11 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 11 to 11; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for ALLY yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Cash from operating activities at least $1.37 billion in 2026-Q1 | Cash from operations rose to $1.37 billion in 2026-Q1. | Intact | Cash from operations falls below $1.37 billion in 2026-Q1 | Cash from operations: $0 FY2026-Q3; GAAP. Published target: >= $1.37 billion. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Oct 20, 20260 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
ALLY is a financial company with a consumer auto lending business, so its multi-year view depends on growth and credit discipline. The thesis is intact, but management delivery is mixed and near-term execution risk remains worth watching.
The evidence describes ALLY as cheap versus peers, with expectations below the model’s baseline. The priced-in assessment is tagged justified, and fragility is low, but valuation has risen recently; the evidence does not show that the gap has closed.
In the latest year-over-year comparison, revenue and consumer auto originations grew, while retail auto charge-offs were nearly unchanged. Core ROTCE, a measure of returns on tangible equity, fell from its earlier level, and deposits were nearly flat despite more new customers. Near term, the company recently reported an earnings beat after a prior miss, but a guidance cut or weaker results remain risks.
The multi-year thesis hinges on growing core businesses while improving returns and maintaining disciplined credit. Near term, a guidance cut or rate cuts could weigh on the financial-sector backdrop, while continued strong results and higher guidance from sector bellwethers could support sector momentum.
Over the next one to three years, ALLY’s thesis rests on whether revenue and auto growth translate into stronger returns without weakening credit quality. The evidence is mixed, but the current thesis remains intact. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in Ally Financial's published investment case. The stated target is Maintain current dividend payout policy. |
| Intact |
| Dividend payout is cut or inconsistent |
Dividend raised 17% vs maintain policy News confirms a 17% dividend increase and Q3 earnings beat, supporting the capital allocation thesis. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Net income at least $319 million in 2026-Q1 | A supporting condition in Ally Financial's published investment case. The stated target is >= $319 million. | Under Pressure | Net income falls below $319 million in 2026-Q1 | Net income: $433M FY2026-Q3; GAAP. Published target: >= $319 million. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Nov 2, 2026433,000,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue at least $7.9 billion in 2025 | A primary condition in Ally Financial's published investment case. The stated target is >= $7.9 billion. | Intact | Revenue falls below $7.9 billion in FY25 | Revenue: $2.332B FY2026-Q3; GAAP. Published target: >= $7.9 billion. Annual target cannot be compared with a quarterly or TTM observation. Nov 2, 20262,332,000,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$6.44 → $6.00 · observed estimates
$9.59B → $9.60B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $6.44 | $9,591,146,690 | 15 / 16 |
| 2026-07-25 | $6.43 | $9,602,112,280 | 16 / 16 |
| 2026-07-26 | $6.43 | $9,602,112,280 | 16 / 16 |
| 2026-07-27 | $6.43 | $9,602,112,280 | 16 / 16 |
| 2026-07-28 | $6.43 | $9,602,112,280 | 16 / 16 |
| 2026-07-29 | $6.44 | $9,606,616,650 | 16 / 16 |
| 2026-07-30 | $6.44 | $9,606,616,650 | 16 / 16 |
| 2026-07-31 | $6.44 | $9,606,616,650 | 16 / 16 |
| 2026-08-01 | $6.44 | $9,606,616,650 | 16 / 16 |
| 2026-08-02 | $6.44 | $9,606,616,650 | 16 / 16 |
| 2026-08-03 | $6.44 | $9,606,616,650 | 16 / 16 |
| 2026-08-04 | $6.44 | $9,606,616,650 | 16 / 16 |
| 2026-08-05 | $6.44 | $9,606,616,650 | 16 / 16 |
| 2026-08-06 | $6.43 | $9,616,530,810 | 16 / 16 |
| 2026-08-07 | $6.42 | $9,652,584,542 | 11 / 11 |
| 2026-08-08 | $6.43 | $9,616,530,810 | 16 / 16 |
| 2026-08-09 | $6.43 | $9,616,530,810 | 16 / 16 |
| 2026-08-10 | $6.43 | $9,616,530,810 | 16 / 16 |
| 2026-08-11 | $6.42 | $9,652,584,542 | 11 / 11 |
| 2026-08-12 | $6.43 | $9,616,530,810 | 16 / 16 |
| 2026-08-13 | $6.43 | $9,616,530,810 | 16 / 16 |
| 2026-08-14 | $6.42 | $9,652,584,542 | 11 / 11 |
| 2026-08-15 | $6.42 | $9,652,584,542 | 11 / 11 |
| 2026-08-16 | $6.42 | $9,652,584,542 | 11 / 11 |
| 2026-08-17 | $6.42 | $9,652,584,542 | 11 / 11 |
| 2026-08-18 | $6.42 | $9,652,584,542 | 11 / 11 |
| 2026-08-19 | $6.42 | $9,652,584,542 | 11 / 11 |
| 2026-08-20 | $6.41 | $9,664,291,621 | 11 / 12 |
| 2026-08-21 | $6.41 | $9,664,291,621 | 11 / 12 |
| 2026-08-22 | $6.41 | $9,664,291,621 | 11 / 12 |
| 2026-08-23 | $6.41 | $9,664,291,621 | 11 / 12 |
| 2026-08-24 | $6.41 | $9,664,291,621 | 11 / 12 |
| 2026-08-25 | $6.41 | $9,664,291,621 | 11 / 12 |
| 2026-08-26 | $6.41 | $9,664,291,621 | 11 / 12 |
| 2026-08-27 | $6.41 | $9,664,291,621 | 11 / 12 |
| 2026-08-28 | $6.41 | $9,664,291,621 | 11 / 12 |
| 2026-08-29 | $6.41 | $9,664,290,051 | 11 / 12 |
| 2026-08-30 | $6.41 | $9,664,290,051 | 11 / 12 |
| 2026-08-31 | $6.41 | $9,664,290,051 | 11 / 12 |
| 2026-09-01 | $6.41 | $9,664,290,051 | 11 / 12 |
| 2026-09-02 | $6.42 | $9,667,735,036 | 11 / 12 |
| 2026-09-03 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-04 | $6.42 | $9,667,734,423 | 12 / 13 |
| 2026-09-05 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-06 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-07 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-08 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-09 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-10 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-11 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-12 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-13 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-14 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-15 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-16 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-17 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-18 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-19 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-20 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-21 | $6.42 | $9,667,734,423 | 12 / 12 |
| 2026-09-22 | $6.39 | $9,651,116,718 | 12 / 12 |
| 2026-09-23 | $6.39 | $9,652,250,051 | 12 / 12 |
| 2026-09-24 | $6.39 | $9,652,250,051 | 12 / 12 |
| 2026-09-25 | $6.39 | $9,652,250,051 | 12 / 12 |
| 2026-09-26 | $6.39 | $9,642,516,991 | 12 / 12 |
| 2026-09-27 | $6.39 | $9,642,516,991 | 12 / 12 |
| 2026-09-28 | $6.39 | $9,642,516,991 | 12 / 12 |
| 2026-09-29 | $6.39 | $9,642,516,991 | 12 / 12 |
| 2026-09-30 | $6.39 | $9,642,516,991 | 12 / 12 |
| 2026-10-01 | $6.34 | $9,631,866,822 | 11 / 12 |
| 2026-10-02 | $6.34 | $9,631,666,822 | 11 / 12 |
| 2026-10-03 | $6.34 | $9,631,666,822 | 11 / 12 |
| 2026-10-04 | $6.34 | $9,631,666,822 | 11 / 12 |
| 2026-10-05 | $6.34 | $9,631,666,822 | 11 / 12 |
| 2026-10-06 | $6.26 | $9,611,272,708 | 11 / 12 |
| 2026-10-07 | $6.23 | $9,605,491,054 | 11 / 12 |
| 2026-10-08 | $6.18 | $9,593,877,797 | 11 / 12 |
| 2026-10-09 | $6.18 | $9,593,877,797 | 11 / 12 |
| 2026-10-10 | $6.18 | $9,593,877,797 | 11 / 12 |
| 2026-10-11 | $6.18 | $9,591,457,797 | 11 / 12 |
| 2026-10-12 | $6.18 | $9,591,457,797 | 11 / 12 |
| 2026-10-13 | $6.12 | $9,580,277,750 | 11 / 12 |
| 2026-10-14 | $6.12 | $9,580,277,750 | 11 / 12 |
| 2026-10-15 | $6.12 | $9,580,277,750 | 11 / 12 |
| 2026-10-16 | $6.12 | $9,580,277,750 | 11 / 12 |
| 2026-10-17 | $6.12 | $9,580,277,750 | 11 / 12 |
| 2026-10-18 | $6.12 | $9,580,277,750 | 11 / 12 |
| 2026-10-19 | $6.12 | $9,580,277,750 | 11 / 12 |
| 2026-10-20 | $6.12 | $9,580,277,750 | 11 / 12 |
| 2026-10-21 | $6.09 | $9,606,828,842 | 11 / 12 |
| 2026-10-22 | $6.09 | $9,606,828,842 | 11 / 12 |
| 2026-10-23 | $6.03 | $9,606,244,699 | 11 / 12 |
| 2026-10-24 | $6.02 | $9,606,334,846 | 11 / 12 |
| 2026-10-25 | $6.02 | $9,606,334,846 | 11 / 12 |
| 2026-10-26 | $6.02 | $9,606,334,846 | 11 / 12 |
| 2026-10-27 | $6.02 | $9,606,334,846 | 11 / 12 |
| 2026-10-28 | $6.02 | $9,606,357,849 | 11 / 12 |
| 2026-10-29 | $6.02 | $9,606,357,849 | 11 / 12 |
| 2026-10-30 | $6.02 | $9,606,357,849 | 11 / 12 |
| 2026-10-31 | $6.02 | $9,606,357,849 | 11 / 11 |
| 2026-11-01 | $6.02 | $9,606,357,849 | 11 / 12 |
| 2026-11-02 | $6.02 | $9,606,357,849 | 11 / 12 |
| 2026-11-03 | $6.00 | $9,598,919,813 | 11 / 12 |
| 2026-11-04 | $6.00 | $9,598,919,813 | 11 / 12 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 13 Buy / Strong Buy · 5 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 11 recorded
0 raises · 4 cuts · 0 unchanged · 3 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.